HIV AND COVID-19: THE WORST OF BOTH WORLDS – EDET IMOH JAMES

HIV AND COVID-19: THE WORST OF BOTH WORLDS – EDET IMOH JAMES

HIV (Human Immunodeficiency Virus) is a Sexually Transmitted Disease that does it’s damage by weakening the immune system over time, thus eliminating its ability to ward off diseases. COVID-19, on the other hand, refers to a disease caused by a new strain of coronavirus.

As HIV progressively weakens the immune system, making it susceptible to a lot of infections, an HIV-positive individual stands a higher chance of contacting COVID-19, and being adversely affected by its effects. Indeed, current research postulates that People Living With HIV (PLWHIV) stand a higher risk of becoming seriously ill from COVID-19. The situation is even more dire for HIV-positive individuals who:

(a) have a low CD4 count (<350 copies/cell)
(b) have a high viral load
(c) a recent opportunistic infection i.e tuberculosis
(d) a current AIDS-defining illness.

Thus, it has become even more imperative for you to know your status, and if positive, to enroll for antiretroviral treatment. If you are currently on ART, it is vital that you stick to your prescription.

The COVID-19 vaccines currently in use are considered safe for people living with HIV. And contrary to popular ideologies, they do not have unknown side effects. Mild to moderate effects include fever, fatigue, headache, muscle pain, chills, diarrhoea, pain at the injection site, and these are generally short-lasting. Severe or long-lasting side effects are possible but extremely rare.

For PLWHIV, they can prevent COVID-19 by following general guidelines, which include:
(i)/Staying at least one metre away from people as much as possible, and even greater distance indoors.
(ii) Wearing a face mask around others.
(iii) Avoiding places that are crowded, confined or involve close contact with others, especially indoors.
(iv) Washing your hands frequently and properly with soap and water, or use an alcohol-based hand sanitiser.
(v) Avoiding touching the face (with your hands)
(vi) Cleaning and disinfecting surfaces regularly.
(vii) Covering your nose and mouth with a clean tissue when you sneeze or cough, or use your elbow. Throw the tissue away and wash your hands afterwards.
(viii) Meeting people you don’t live with outdoors, as it’s safer to meet outside than inside.
(ix) Keeping indoor spaces well ventilated, by opening windows and doors, if you do meet people inside.
By complying with the aforementioned COVID-19 safety precautions, and adhering to treatment, PLWHIV can live the best life possible!!!

HIV SELF-TEST – IMOH EDET

HIV SELF-TEST – IMOH EDET

When you hear of HIV Self-Test Kits what comes to your mind? I’m sure your guess is as good as mine. HIV Self-Testing can be defined as the process by which a person who is interested in knowing their HIV status collects his or her own specimen (oral fluid or blood), performs the HIV test, and subsequently interprets the result. This is often effected in a private setting, with the self-tester being either alone or with someone he or she trusts.

HIV Self-Tests are only able to detect HIV antibodies, and are thus referred to as second-or-third generation HIV tests (second and third generation tests can accurately detect long-standing HIV infection, but their ability to detect recently acquired HIV is more variable).
A popular example of HIV-Self Test is the OraQuick HIV Self-Test. The OraQuick HIV Self-Test uses oral fluid to check for antibodies to HIV Type-1 and HIV Type-2, viruses that can cause AIDS. It consists of a stick (device) to collect the specimen, a test tube (vial) to insert the test stick and complete the test, testing directions, two information booklets, a disposal bag and phone numbers for consumer support.

Directions For Use:
(1) Swab your upper and lower gums with the test kit (which contains an absorbent pad) to collect the oral sample.
(2) Insert the device into the kit’s vial which contains a developer’s solution.
(3) Wait 20-40 minutes (you need to watch to record the time of the reaction of the test before reading your result).
(4)) Read the test result.

The result of HIV Self-Testing could be reactive, non-reactive or invalid.
A reactive result is when the test indicates that HIV antibodies are present in the oral fluid sample used for the test. Here, two RED lines show on the T and C marks in the result window of the test device. A positive result with this test does not mean that an individual is definitely infected with HIV but rather that additional testing should be done in a medical setting to confirm the test result.

A negative result is when the test indicates that HIV antibodies are absent in the oral fluid sample used for the test. Here, one RED line shows on the C mark in the result window of the test device. A positive result with this test does not mean that an individual is definitely not infected with HIV, particularly when exposure may have been within the previous three months. Again, an individual should obtain a confirmatory test in a medical setting.

An Invalid Result could also be obtained using the OraQuick HIV Self-Test. This occurs either: (a) where no red line appears in the T or C marks. (b) where a line appears in the T mark but not on the C. An Invalid result can happen when: (a) the person conducting the test lacks the knowledge and skill on how to do it. (b) when he or she does not follow the instruction manual properly. (c) when the test kit is not good.

OraQuick HIV Self-Test could be conducted either by: (a) Directly Assisted (b) Unassisted methods. The former refers to the presence of a learned provider or peer who gives the individual about to carry out the self-test an in-person demonstration, before or during the self-testing on how to perform and/or interpret the test reusult. (b) Unassisted Methods connotes the self-execution of the test following the instruction manual provided in the pack of the kit by the manufacturer.

Clinical studies have shown that the OraQuick HIV Self-Test has approximately 92% accuracy for test sensitivity (the percentage of results that will be positive when HIV is present. In a similar vein, the self-test kit has been discovered to be 99.8% when testing for test specificity (the percentage of results that will be negative when HIV is not present).

It is extremely vital that, when using the OraQuick Self-Test Kit, you carefully read and follow all labeled directions. This is so as to prevent a false positive result, an invalid result, or no result.

MICROBICIDES AND HIV: PREVENTION UNDER PROSPECTION – EDET IMOH JAMES

MICROBICIDES AND HIV: PREVENTION UNDER PROSPECTION – EDET IMOH JAMES

Microbicides can be defined as products that could be applied inside the vagina or rectum to protect people from being infected with HIV. Microbicides are biomedical and topical in nature. The principal aim of microbicides is to reduce or prevent HIV transmission. Microbicides work by killing or destroying viruses capable of causing HIV, or other STIs. Examples of microbicides include vaginal rings, gels, films, inserts, suppositories, foams or enemas, slow-releasing sponges and aerosols. Through microbicides, the number of biomedical HIV prevention options available would be greatly expanded.

Microbicides can be of great importance to people who are unable to or refuse to use condom, particularly female sex workers who may encounter ‘customers’ adverse to condom use. There are several microbicide products being developed in various stages , but a finalized safe and effective microbicide is not yet available. Microbicides are an offshoot of the Combination Prevention Approach, which advocates tailoring and coordinating Biomedical, Behavioral and Structural strategies to reduce new HIV infections. As an example, sexual abstinence is not a realistic option for married women , women who want to bear children, or who are at ask of sexual violence. In such situations, usage of microbicides could offer protection in two ways: (a) where no condom is used (b) if the condom breaks or slips off during sexual intercourse. Thus, an effective microbicide may serve to bridge a gap in current HIV prevention strategies: lack of a discreet method that women can use to protect themselves from infection.

Also, since microbicides are topical (applied to only parts of the body), this allows for higher drug concentrations to be delivered to virally exposed surfaces without significant systemic exposure, thus reducing the risk of long-term toxicity in healthy but at risk individuals. In all, the invention of microbicides can indisputably be affirmed as being one of HIV prevention science’s greatest breakthroughs.

PREVENTING HIV TRANSMISSIONS WITHIN SERO-DISCORDANT COUPLES – EDET IMOH JAMES

PREVENTING HIV TRANSMISSIONS WITHIN SERO-DISCORDANT COUPLES – EDET IMOH JAMES

A sero-discordant couple-also referred to as a couple of mixed-status- is a relationship where one partner is infected by HIV and the other is not. A sero-discordant couple can also be used to describe a relationship where one person’s blood tests positive for HIV and the other does not. There are high risks and rates of HIV acquisition and transmission in serodiscordant relationships. Studies in sub-saharan Africa have found that women living with HIV positive partners were 37.9% to 105.8% times more likely to seroconvert than those living in concordant-negative partnerships. A 2013 modeling study among 20 countries in sub-saharan Africa estimated that 29% of new infections occurred within stable serodiscordant couples. Among MSMs, an estimated 33-67% of new HIV infections occur within a primary relationship.

Preventing HIV transmission within sero-discordant couples involves the utilization of various methods. These include:

Behavioral Approach: This includes couples HIV Testing and Counseling (HTC). Couples HIV Testing and Counseling (CHTC) increases testing, condom use, and decreases seroconversion. Behavioral approach also embodies Couple-Based Interventions which are designed specifically for couples. These programs promote established risk-reduction behaviors (e.g condom use, decreasing the number of sexual partners etc) as well as couple-relevant strategies including communication and negotiation skills.

Biomedical Approach: This encompasses the use of medical treatments to reduce the transmission of HIV. Biomedical approaches include ARVs for prevention or post-exposure prophylaxis, barrier methods such as male and female condoms, procedures such as medical male circumcision or other methods to eliminate risk of HIV transmission. Biomedical approaches also encompasses testing and treatment for sexually transmitted infections, which are common among people living with HIV and amplify transmission. Thus, it is vital that partners within serodiscordant relationships should be regularly tested as STI may increase both transmission and acquisition vulnerability for HIV.

Treatment as prevention (TasP) refers to HIV prevention methods and programmes that use antiretroviral treatment (ART) to decrease the risk of HIV transmission. When adhered to consistently, ART can reduce the HIV viral load in an individual’s blood, semen, vaginal fluid and rectal fluid to such a low level that blood tests can’t detect it. Thus Undetectable=Untransmittable. An HIV-positive partner can protect himself and his partner by unflinchingly adhering to his medication. An HIV-positive partner with an undetectable viral load is extremely unlikely to transmit HIV through sexual contact. However, safe sex practices still need to be effected.

Pre-exposure Prophylaxis (PrEP) is a form of HIV prevention that uses anti-HIV drugs to protect HIV-negative people from acquiring HIV. With PrEP, the uninfected partner is treated with an HIV drug, which reduces his chances of contracting the virus. However, PrEP is neither perfect, nor does it protect against other sexually transmitted infections. Thus, both partners should use condoms while engaging in sexual intercourse.

If a woman who has HIV gets pregnant, there are recommendations for reducing the risk that her infant will be born HIV positive. The most important is to have adequate prenatal care and appropriate treatment for HIV. In addition, the infant may need to be treated after birth. For women whose HIV is not fully suppressed, a cesarean section might be scheduled before the membranes rupture. This has the potential to reduce the risk that the baby will be exposed to HIV during delivery. Also, When the female partner is the one who is HIV positive, she can be inseminated with her partner’s sperm using artificial insemination, in vitro-fertilization, or intrauterine insemination. With these methods, partners don’t need to have unprotected sex to conceive. If the male partner is the one who is HIV positive, options include using a sperm donor and/or washing sperm. Men can also make certain that their viral load is suppressed as fully as possible before having unprotected sex in an attempt to conceive.
In summary, HIV is not a death sentence, health-wise and relationship-wise. With proper precautions and the right dispositions, couples can live the best life possible!!!

HIV NO BE DEATH SENTENCE – Peter Edokpaigbe

HIV NO BE DEATH SENTENCE – Peter Edokpaigbe

 

When person do HIV test and he con dey positive to HIV e no mean say the person go die, e no still mean say life don end, e also no mean say you no go fit marry or born o my brother, my sister. When person test positive for HIV for health center, them go enroll the person into care, this one mean say them go start to dey give the person drugs wey dem call ARV(Antiretroviral Drugs). The medicine go make you live long, and make the HIV virus for the person body reduce to the level wey the person no go fit transfer the HIV virus to another person (either em wife or em husband or e fit even be em sexual partners). The good thing be say you go com fit live positively fine if you use the medicine as doctor or healthcare provider don tell you make you use am.

You don com see say to get HIV no be death sentence? If you do your test and you begin dey use your drugs very well as doctor talk say make you dey use am everyday.

PETER EDOKPAIGBE
LENNIB CHAMPION.

HIV NO BE DEATH SENTENCE – Peter Edokpaigbe

POST EXPOSURE PROPHYLAXIS: NOT MEDICINE AFTER DEATH – Edet Imoh James

Alongside notable breakthroughs in the HIV/AIDS prevention spectrum was the invention of PEP (Post-Exposure Prophylaxis) which is a combination of HIV drugs (tenofovir, emtricitabine, and dolutegravir or raltegravir) that is taken as soon as there is a possible exposure to HIV to prevent the virus from taking hold in your body. PEP is most effective when started within 24 hours, but is is vital that it be commenced at most, within 72 hours following the possible exposure. After 72 hours, PEP is usually not given as research has shown that it is unlikely to be efficacious. PEP is usually taken once or twice a day for 28 days.
Even while you are on PEP, it is nevertheless still vital that you use your condoms during sex to reduce your chances of coming in contact with HIV again, or if you have the virus, that you’ll spread it.
PEP may help:
(1) People who think they might have been exposed to HIV during sex.
(2) People who have been sexually assaulted.
(3) Drug users who have recently shared needles or other related items.
(4) Health workers who think they’ve been exposed to HIV on the job.
After completing the prescription, you’ll need to undergo another HIV test to affirm that you do not have the virus.

PEP is however only for emergencies. It should not be substituted for safe sex or sterilized needles. If you are exposed to HIV a lot ie. having multiple sex partners, its best to see a doctor about using PrEP (pre-exposure prophylaxis). These are drugs that are used before engaging in a risky behavior which could predispose you to contracting HIV.

Side effects of PEP include:
(1) Upset Stomach (ii) Fatigue (iii) Headache (iv) Diarrhea (v) Insomnia. In rare cases, PEP can cause serious health issues, including liver problems.
Just like every other medication, PEP is not to be self-diagnosed. It is best to see a doctor or another qualified medical practitioner to certify your eligibility and monitor you as you use the drugs.

While PEP exists and is effective, it should be treated as the exception, not the norm. Let condoms, PrEP and lubricants be your body armor as you engage in risky behaviors which could make you susceptible to contracting HIV.

Nevertheless PEP is no medicine after death, as although you might have contracted the virus, the drug can stop the virus as it tries to infection you. However this is only possible if you take the drugs within the stipulated time-frame (72 hours) and you adhere to your prescriptions at the right dosage and at the same time daily (for 28 days).

Hope you had an enjoyable read!!!